Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients

Menno Tamminga(University Medical Center Groningen), Harry J.M. Groen(University Medical Center Groningen)

Translational Lung Cancer Research

August 1, 2020

10.21037/tlcr-19-413

Cited by 11

Related Papers

Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET

|Diabetes Care|2017|163

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET

|Cancers|2020|55

OA 05.05 Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial

|Journal of Thoracic Oncology|2017|20

P1.01-001 Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial

|Journal of Thoracic Oncology|2017|3